Share This Article:

Carbonic anhydrase VII–a potential prognostic marker in gliomas

Full-Text HTML Download Download as PDF (Size:359KB) PP. 6-12
DOI: 10.4236/health.2011.31002    3,553 Downloads   7,272 Views   Citations

ABSTRACT

Carbonic anhydrase VII (CA VII) is a cytosolic enzyme expressed in several organs, including the human brain, but it has not been investigated earlier in any tumors. We designed the present study to evaluate CA VII expression in a cohort of human diffuse astrocytomas, mixed oligoastrocytomas and oligodendrogliomas. CA VII immunostaining was correlated to clinico-pathologic findings, survival data, and expres-sion of other molecular factors, including Ki-67, p53 protein and epidermal growth factor receptor. CA VII-positive staining was observed in 94% of astrocytomas and 85% of oligodendrogliomas. In the tumor specimens, strong positive areas were often located in close proximity to necrosis. The CA VII immunoreactivity showed positive correlation with tumor malignancy grades of astrocytomas (p = 0.02, chi-square test). In all tumor categories, CA VII-positive staining was often seen in the en-dothelial cells of neovessels in addition to the tumor cells. CA VII intensity showed no significant association with p53 nor did it correlate with the amplification of epidermal growth factor receptor (analyzed only in astrocytomas) or cell proliferation. Our present results show that CA VII may act as a useful biomarker in histopathologic diagnostics of gliomas. The high expression of CA VII in the tumor cells and endothelium suggests important roles for the enzyme in tumor metabolism. The results also led us to conclude that CA VII might serve as a marker of poor prognosis in diffuse astrocytomas.

Cite this paper

Bootorabi, F. , Haapasalo, J. , Smith, E. , Haapasalo, H. and Parkkila, S. (2011) Carbonic anhydrase VII–a potential prognostic marker in gliomas. Health, 3, 6-12. doi: 10.4236/health.2011.31002.

References

[1] Sly, W.S. and Hu, P.Y. (1995) Human carbonic anhydrases and carbonic anhydrase deficiencies. Annual Reviews of Biochemistry, 64, 375-401. doi:10.1146/annurev.bi.64.070195.002111
[2] Parkkila, S. and Parkkila, A.K. (1996) Carbonic anhydrase in the alimentary tract. Roles of the different isozymes and salivary factors in the maintenance of optimal conditions in the gastrointestinal canal. Scandinavian Journal of Gastroenterology, 31, 305-317. doi:10.3109/00365529609006403
[3] Hewett-Emmett, D. and Tashian, R.E. (1996) Functional diversity, conservation, and convergence in the evolution of the alpha-, beta-, and gamma-carbonic anhydrase gene families. Molecular Phylogenetics and Evolution, 5, 50- 77. doi:10.1006/mpev.1996.0006
[4] Lehtonen, J., Shen, B., Vihinen, M., Casini, A., Scozzafava, A., Supuran, C.T., Parkkila, A.K., Saarnio, J., Kivela, A.J., Waheed, A., Sly, W.S. and Parkkila, S. (2004) Characterization of CA XIII, a novel member of the carbonic anhydrase isozyme family. Journal of Biological Chemistry, 279, 2719-2727. doi:10.1074/jbc.M308984200
[5] Pastorekova, S., Parkkila, S., Pastorek, J. and Supuran, C.T. (2004) Carbonic anhydrases: current state of the art, therapeutic applications and future prospects. Journal of Enzyme Inhibition and Medicinal Chemistry, 19, 199- 229. doi:10.1080/14756360410001689540
[6] Haapasalo, J., Nordfors, K., Jarvela, S., Bragge, H., Rantala, I., Parkkila, A.K., Haapasalo, H. and Parkkila, S. (2007) Carbonic anhydrase II in the endothelium of glial tumors: a potential target for therapy. Neuro-Oncology, 9, 308-313. doi:10.1215/15228517-2007-001
[7] Haapasalo, J.A., Nordfors, K.M., Hilvo, M., Rantala, I.J., Soini, Y., Parkkila, A.K., Pastorekova, S., Pastorek, J., Parkkila, S.M. and Haapasalo, H.K. (2006) Expression of carbonic anhydrase IX in astrocytic tumors predicts poor prognosis. Clinical Cancer Research, 12, 473-477. doi:10.1158/1078-0432.CCR-05-0848
[8] Said, H.M., Hagemann, C., Staab, A., Stojic, J., Kuhnel, S., Vince, G.H., Flentje, M., Roosen, K. and Vordermark, D. (2007) Expression patterns of the hypoxia-related genes osteopontin, CA9, erythropoietin, VEGF and HIF- 1alpha in human glioma in vitro and in vivo. Radiotherapy and Oncology, 83, 398-405. doi:10.1016/j.radonc.2007.05.003
[9] Said, H.M., Polat, B., Staab, A., Hagemann, C., Stein, S., Flentje, M., Theobald, M., Katzer, A. and Vordermark, D. (2008) Rapid detection of the hypoxia-regulated CA-IX and NDRG1 gene expression in different glioblastoma cells in vitro. Oncology Reports, 20, 413-419.
[10] Ihnatko, R., Kubes, M., Takacova, M., Sedlakova, O., Sedlak, J., Pastorek, J., Kopacek, J. and Pastorekova, S. (2006) Extracellular acidosis elevates carbonic anhydrase IX in human glioblastoma cells via transcriptional modu- lation that does not depend on hypoxia. International Journal of Oncology, 29, 1025-1033.
[11] Ivanov, S., Liao, S.Y., Ivanova, A., Danilkovitch- Miagkova, A., Tarasova, N., Weirich, G., Merrill, M.J., Proescholdt, M.A., Oldfield, E.H., Lee, J., Zavada, J., Waheed, A., Sly, W., Lerman, M.I. and Stanbridge, E.J. (2001) Expression of hypoxia-inducible cell-surface transmembrane carbonic anhydrases in human cancer. American Journal of Pathology, 158, 905-919.
[12] Alterio, V., Hilvo, M., Di Fiore, A., Supuran, C.T., Pan, P., Parkkila, S., Scaloni, A., Pastorek, J., Pastorekova, S., Pedone, C., Scozzafava, A., Monti, S.M. and De Simone, G. (2009) Crystal structure of the catalytic domain of the tumor-associated human carbonic anhydrase IX. Proceedings of the National Academy of Sciences USA, 106, 16233-16238. doi:10.1073/pnas.0908301106
[13] Baranauskiene, L., Hilvo, M., Matuliene, J., Golovenko, D., Manakova, E., Dudutiene, V., Michailoviene, V., Torresan, J., Jachno, J., Parkkila, S., Maresca, A., Supuran, C.T., Grazulis, S. and Matulis, D. (2010) Inhibition and binding studies of carbonic anhydrase isozymes I, II and IX with benzimidazo[1,2-c][1,2,3] thiadiazole-7-sul-pho- namides. Journal of Enzyme Inhibition and Medicinal Chemistry, 25, 863-870. doi:10.3109/14756360903571685
[14] Montgomery, J.C., Venta, P.J., Eddy, R.L., Fukushima, Y.S., Shows, T.B. and Tashian, R.E. (1991) Characterization of the human gene for a newly discovered carbonic anhydrase, CA VII, and its localization to chromosome 16. Genomics, 11, 835-848. doi:10.1016/0888-7543(91)90006-Z
[15] Lakkis, M.M., Bergenhem, N.C. and Tashian, R.E. (1996) Expression of mouse carbonic anhydrase VII in E. coli and demonstration of its CO2 hydrase activity. Biochemical and Biophysical Research Communications, 226, 268-272. doi:10.1006/bbrc.1996.1344
[16] Vullo, D., Innocenti, A., Nishimori, I., Scozzafava, A., Kaila, K. and Supuran, C.T. (2007) Carbonic anhydrase activators: activation of the human isoforms VII (cytosolic) and XIV (transmembrane) with amino acids and amines. Bioorganic and Medicinal Chemistry Letters, 17, 4107-4112. doi:10.1016/j.bmcl.2007.05.052
[17] Gitto, R., Agnello, S., Ferro, S., Vullo, D., Supuran, C.T. and Chimirri, A. (2010) Identification of potent and selective human carbonic anhydrase VII (hCA VII) inhibitors. ChemMedChem, 5, 823-826.
[18] Halmi, P., Parkkila, S. and Honkaniemi, J. (2006) Expression of carbonic anhydrases II, IV, VII, VIII and XII in rat brain after kainic acid induced status epilepticus. Neurochemistry International, 48, 24-30. doi:10.1016/j.neuint.2005.08.007
[19] Kleihues, P., Louis, D.N., Scheithauer, B.W., Rorke, L.B., Reifenberger, G., Burger, P.C. and Cavenee, W.K. (2002) The WHO classification of tumors of the nervous system. Journal of Neuropathology and Experimental Neurology, 61, 215-225.
[20] Louis, D.N., Ohgaki, H., Wiestler, O.D., Cavenee, W.K., Burger, P.C., Jouvet, A., Scheithauer, B.W. and Kleihues, P. (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathologica, 114, 97- 109. doi:10.1007/s00401-007-0243-4
[21] Bootorabi, F., Janis, J., Smith, E., Waheed, A., Kukkurainen, S., Hytonen, V., Valjakka, J., Supuran, C.T., Vullo, D., Sly,W.S. and Parkkila, S. (2010) Analysis of a shortened form of human carbonic anhydrase VII expressed in vitro compared to the full-length enzyme. Biochimie, 92, 1072-1080.
[22] Leppilampi, M., Saarnio, J., Karttunen, T.J., Kivela, J., Pastorekova, S., Pastorek, J., Waheed, A., Sly and W.S., Parkkila, S. (2003) Carbonic anhydrase isozymes IX and XII in gastric tumors. World Journal of Gastroenterology, 9, 1398-1403.
[23] Haapasalo, H., Sallinen, S., Sallinen, P., Helen, P., Jaaskelainen, J., Salmi, T.T., Paetau, A., Paljarvi, L., Visakorpi, T. and Kalimo, H. (1999) Clinicopathological correlation of cell proliferation, apoptosis and p53 in cerebellar pilocytic astrocytomas. Neuropathology and Applied Neurobiology, 25, 134-142. doi:10.1046/j.1365-2990.1999.00157.x
[24] Jarvela, S., Helin, H., Haapasalo, J., Jarvela, T., Junttila, T.T., Elenius, K., Tanner, M., Haapasalo, H. and Isola, J. (2006) Amplification of the epidermal growth factor receptor in astrocytic tumours by chromogenic in situ hybridization: association with clinicopathological features and patient survival. Neuropathology and Applied Neurobiology, 32, 441-450.
[25] Haapasalo, J., Hilvo, M., Nordfors, K., Haapasalo, H., Parkkila, S., Hyrskyluoto, A., Rantala, I., Waheed, A., Sly, W.S., Pastorekova, S., Pastorek, J. and Parkkila, A.K. (2008) Identification of an alternatively spliced isoform of carbonic anhydrase XII in diffusely infiltrating astrocytic gliomas. Neuro-Oncology, 10, 131-138.
[26] Nordfors, K., Haapasalo, J., Korja, M., Niemela, A., Laine, J., Parkkila, A.K., Pastorekova, S., Pastorek, J., Waheed, A., Sly, W.S., Parkkila, S. and Haapasalo, H. (2010) The tumour-associated carbonic anhydrases CA II, CA IX and CA XII in a group of medulloblastomas and supratentorial primitive neuroectodermal tumours: an association of CA IX with poor prognosis. BMC Cancer, 10, 148. doi:10.1186/1471-2407-10-148
[27] Maseide, K., Kandel, R.A., Bell, R.S., Catton, C.N., O'Sullivan, B., Wunder, J.S., Pintilie, M., Hedley and D., Hill, R.P. (2004) Carbonic anhydrase IX as a marker for poor prognosis in soft tissue sarcoma. Clinical Cancer Research, 10, 4464-4471. doi:10.1158/1078-0432.CCR-03-0541
[28] Kon-no, H., Ishii, G., Nagai, K., Yoshida, J., Nishimura, M., Nara, M., Fujii, T., Murata, Y., Miyamoto, H. and Ochiai, A. (2006) Carbonic anhydrase IX expression is associated with tumor progression and a poor prognosis of lung adenocarcinoma. Lung Cancer, 54, 409-418.
[29] Korkeila, E., Talvinen, K., Jaakkola, P.M., Minn, H., Syrjanen, K., Sundstrom, J. and Pyrhonen, S. (2009) Expression of carbonic anhydrase IX suggests poor outcome in rectal cancer. British Journal of Cancer, 100, 874-880. doi:10.1038/sj.bjc.6604949
[30] Liao, S.Y., Darcy, K.M., Randall, L.M., Tian, C., Monk, B.J., Burger, R.A., Fruehauf, J.P., Peters, W.A., Stock, R.J. and Stanbridge, E.J. (2010) Prognostic relevance of carbonic anhydrase-IX in high-risk, early-stage cervical cancer: A Gynecologic Oncology Group study. Gynecological Oncology, 116, 452-458.
[31] Klatte, T., Seligson, D.B., Rao, J.Y., Yu, H., De Martino M., Kawaoka, K., Wong, S.G., Belldegrun, A.S. and Pantuck, A.J. (2009) Carbonic anhydrase IX in bladder cancer: A diagnostic, prognostic, and therapeutic molecular marker. Cancer, 115, 1448-1458.
[32] Choi, S.W., Kim, J.Y., Park, J.Y., Cha, I.H., Kim, J. and Lee, S. (2008) Expression of carbonic anhydrase IX is associated with postoperative recurrence and poor prognosis in surgically treated oral squamous cell carcinoma. Human Pathology, 39, 1317-1322.
[33] Belldegrun, A.S. and Bevan, P. (2008) Carbonic anhydrase IX: Role in diagnosis prognosis and cancer therapy. Introduction. British Journal of Urology International, 101, 1.
[34] Hussain, S.A., Ganesan, R., Reynolds, G., Gross, L., Stevens, A., Pastorek, J., Murray, P.G., Perunovic, B., Anwar, M.S., Billingham, L., James, N.D., Spooner, D., Poole, C.J., Rea, D.W. and Palmer, D.H. (2007) Hypoxia-regulated carbonic anhydrase IX expression is associated with poor survival in patients with invasive breast cancer. British Journal of Cancer, 96, 104-109.
[35] Lakkis, M.M., O'Shea, K.S. and Tashian, R.E. (1997) Differential expression of the carbonic anhydrase genes for CA VII (Car7) and CA-RP VIII (Car8) in mouse brain. Journal of Histochemistry and Cytochemistry, 45, 657- 662.
[36] Ruusuvuori, E., Li, H., Huttu, K., Palva, J.M., Smirnov, S., Rivera, C., Kaila, K. and Voipio, J. (2004) Carbonic anhydrase isoform VII acts as a molecular switch in the development of synchronous gamma-frequency firing of hippocampal CA1 pyramidal cells. Journal of Neuroscience, 24, 2699-2707. doi:10.1523/JNEUROSCI.5176-03.2004
[37] Said, H.M., Staab, A., Hagemann, C., Vince, G.H., Katzer, A., Flentje, M. and Vordermark, D. (2007) Distinct patterns of hypoxic expression of carbonic anhydrase IX (CA IX) in human malignant glioma cell lines. Journal of Neurooncology, 81, 27-38.
[38] Wykoff, C.C., Beasley, N.J., Watson, P.H., Turner, K.J., Pastorek, J., Sibtain, A., Wilson, G.D., Turley, H., Talks, K.L., Maxwell, P.H., Pugh, C.W., Ratcliffe, P.J. and Harris, A.L. (2000) Hypoxia-inducible expression of tumor- associated carbonic anhydrases. Cancer Research, 60, 7075-7083.
[39] Korkolopoulou, P., Perdiki, M., Thymara, I., Boviatsis, E., Agrogiannis, G., Kotsiakis, X., Angelidakis, D., Rologis, D., Diamantopoulou, K., Thomas-Tsagli, E., Kaklamanis, L., Gatter, K. and Patsouris, E. (2007) Expression of hypoxia-related tissue factors in astrocytic gliomas. A multivariate survival study with emphasis upon carbonic anhydrase IX. Human Pathology, 38, 629-638.
[40] Supuran, C.T. (2008) Carbonic anhydrases: novel therapeutic applications for inhibitors and activators. Nature Reviews Drug Discovery, 7, 168-181. doi:10.1038/nrd2467
[41] Pastorekova, S., Parkkila, S. and Zavada, J. (2006) Tumor-associated carbonic anhydrases and their clinical significance. Advances in Clinical Chemistry, 42, 167- 216. doi:10.1016/S0065-2423(06)42005-9
[42] Xiang, Y., Ma, B., Yu, H.M. and Li, X.J. (2004) The protein profile of acetazolamide-treated sera in mice bearing Lewis neoplasm. Life Science, 75, 1277-1285.
[43] Supuran, C.T., Briganti, F., Tilli, S., Chegwidden, W.R. and Scozzafava, A. (2001) Carbonic anhydrase inhibitors: sulfonamides as antitumor agents? Bioorganic and Medicinal Chemistry, 9, 703-714. doi:10.1016/S0968-0896(00)00288-1
[44] Supuran, C.T. (2003) Indisulam: An anticancer sulfonamide in clinical development. Expert Opinion onInvestigational Drugs, 12, 283-287.

  
comments powered by Disqus

Copyright © 2018 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.